ADNI data is made available to researchers around the world. As such, there are many active research projects accessing and applying the shared ADNI data. To further encourage Alzheimer’s disease research collaboration, and to help prevent duplicate efforts, the list below shows the specific research focus of the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Michael Irizarry |
| Institution: | GlaxoSmithKline |
| Department: | WW Epidemiology |
| Country: | United States of America |
| Proposed Analysis: | The aims of this study are to identify factors associated with change in cognitive scores over time in AD, MCI, and normal controls. The effect of baseline clinical, demographic, biochemical, imaging and genetic factors on change in ADAS-cog will be assessed by univariate, multivariate, and datamining methods. |
| Additional Investigators |